Patterns of inflammation and the use of reversibility testing in smokers with airway complaints - Wikidata - awgldk - TriplyDB

Patterns of inflammation and the use of reversibility testing in smokers with airway complaints

Patterns of inflammation and the use of reversibility testing in smokers with airway complaints

http://www.wikidata.org/entity/Q33245416

about

Assessment of asthma and chronic obstructive pulmonary disorder in relation to reversibility, IgE, eosinophil, and neutrophil count in a University Teaching Hospital in South Delhi, India.Targeted treatment in COPD: a multi-system approach for a multi-system disease.

P2860

Q34373833-65513688-6B65-4C45-8295-7E073EF85866 Q37340178-2A431D6C-6E94-4109-A4F8-16F9687612EB

P2860

Patterns of inflammation and the use of reversibility testing in smokers with airway complaints

http://www.wikidata.org/entity/Q33245416

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Patterns of inflammation and t ...... smokers with airway complaints

@ast

Patterns of inflammation and t ...... smokers with airway complaints

@en

type

label

Patterns of inflammation and t ...... smokers with airway complaints

@ast

Patterns of inflammation and t ...... smokers with airway complaints

@en

prefLabel

Patterns of inflammation and t ...... smokers with airway complaints

@ast

Patterns of inflammation and t ...... smokers with airway complaints

@en

P1433

Q33245416-1150421F-21AC-4C3D-8932-00E3F7E3A996

P1476

Q33245416-579C6F58-09F1-4DE5-A12F-A4178B6EF443

P2093

Q33245416-27D55499-6B45-4011-B6DF-5E5A91922800

Q33245416-48B27DED-DEA0-4984-AF4C-E111553899CB

Q33245416-64F8AD2A-7F3F-4FD4-82F3-59F84269C0BD

Q33245416-C4D60862-1CC0-457D-83E4-48EE8E35FFB7

Q33245416-CB2E77DC-0F43-4856-BF85-0306013AC12A

Q33245416-F732E786-A36A-4835-BB7B-63717D171298

P2860

Q33245416-07EF993E-A66A-48A9-897A-4C9CBFC6A772

Q33245416-08BB1747-03CD-40AE-BB47-65695A75F63C

Q33245416-0D86582F-58E0-4F58-BD16-865D8C422461

Q33245416-1C7CAA85-F2ED-422A-9C33-278C03B2BDA8

Q33245416-33993DAF-B72D-4A4C-A01C-B0F30344B341

Q33245416-45ABAD5C-47EA-4F29-A3C0-13E7A8BA0A21

Q33245416-5232B93B-6E19-48DE-8FF6-F35D57A8149B

Q33245416-5A92C4DE-8834-4A2A-A942-389FAE44EB3F

Q33245416-82078863-1C2D-4D36-A50B-D437FBAE33AF

Q33245416-824157F0-E9CF-4EF6-B3D1-65711E686E6D

P2888

Q33245416-D511E551-4FEF-4609-8A10-EAE5457CCCFE

P304

Q33245416-72D14D6D-56AD-4FAE-9B9D-4736C65EA47B

P31

Q33245416-7A78EE1B-7A81-4C73-8832-F389C71A9997

P356

Q33245416-B9F4379A-8BA7-4D33-AEAD-8B804974D65D

P478

Q33245416-379BB031-D658-4CAC-9559-A0EFB3CBFBDE

P50

Q33245416-014793D1-B25F-4E96-9346-320D81E9298D

Q33245416-86995125-7F4E-4EF4-A04B-0BAC842BFBD8

P577

Q33245416-1FD28B86-5D5A-4844-90F3-DA78158F0E34

P5875

Q33245416-B0C7F431-7BF8-4553-AE0B-5E72C17984AB

P6179

Q33245416-8EC75AFA-BA2A-47D8-AC8F-539F9AA732CC

P698

Q33245416-DEB0B377-037C-4AC2-AF58-BE72CAF83A7A

P921

Q33245416-4A0DF266-1CA7-4394-AADB-25C54F9381FC

P932

Q33245416-695F6B0C-F186-4C60-95E3-9EC41A2B1385

P356

P1433

BMC Pulmonary Medicine

P1476

Patterns of inflammation and t ...... smokers with airway complaints

@en

P2093

Emiel F M Wouters

http://www.w3.org/2001/XMLSchema#string

Jan A Jacobs

http://www.w3.org/2001/XMLSchema#string

Juanita H J Vernooy

http://www.w3.org/2001/XMLSchema#string

Mieke A Dentener

http://www.w3.org/2001/XMLSchema#string

Onno C P van Schayck

http://www.w3.org/2001/XMLSchema#string

Tjard R J Schermer

http://www.w3.org/2001/XMLSchema#string

P2860

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.

Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.

Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD)

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.

Evaluation of measurement of human TNF in plasma by ELISA.

Eosinophilic bronchitis is an important cause of chronic cough.

Smoking and airway inflammation in patients with mild asthma.

P2888

P304

11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2466-6-11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Niels H Chavannes

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7043108

http://www.w3.org/2001/XMLSchema#string

P6179

1043464671

http://www.w3.org/2001/XMLSchema#string

P698

16740168

http://www.w3.org/2001/XMLSchema#string

P921

P932

1513598

http://www.w3.org/2001/XMLSchema#string